Skip to main content
British Journal of Cancer logoLink to British Journal of Cancer
. 2001 Jul;85(1):98–101. doi: 10.1054/bjoc.2001.1857

Tcf-3 expression and β -catenin mediated transcriptional activation in aggressive fibromatosis (desmoid tumour)

S Tejpar 1,2, C Li 1, C Yu 1, R Poon 1, H Denys 2, R Sciot 3, E Van Cutsem 4, J J Cassiman 2, B A Alman 1,5
PMCID: PMC2363921  PMID: 11437409

Abstract

Aggressive fibromatosis harbours mutations resulting in β-catenin protein stabilization. Primary cell cultures demonstrate constitutive tcf activation in aggressive fibromatosis. Expression and co-immunoprecipitation studies suggest that β-catenin binds and activates tcf-3 in this tumour. This is the first demonstration of tcf-3 activation by β-catenin stabilization in a human neoplastic process. © 2001 Cancer Research Campaign http://www.bjcancer.com

Keywords: β-catenin, tcf/lef transcription factors, aggressive fibromatosis, APC

Full Text

The Full Text of this article is available as a PDF (79.5 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alman B. A., Li C., Pajerski M. E., Diaz-Cano S., Wolfe H. J. Increased beta-catenin protein and somatic APC mutations in sporadic aggressive fibromatoses (desmoid tumors). Am J Pathol. 1997 Aug;151(2):329–334. [PMC free article] [PubMed] [Google Scholar]
  2. Alman B. A., Pajerski M. E., Diaz-Cano S., Corboy K., Wolfe H. J. Aggressive fibromatosis (desmoid tumor) is a monoclonal disorder. Diagn Mol Pathol. 1997 Apr;6(2):98–101. doi: 10.1097/00019606-199704000-00005. [DOI] [PubMed] [Google Scholar]
  3. Barker N., Huls G., Korinek V., Clevers H. Restricted high level expression of Tcf-4 protein in intestinal and mammary gland epithelium. Am J Pathol. 1999 Jan;154(1):29–35. doi: 10.1016/S0002-9440(10)65247-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Barker N., Morin P. J., Clevers H. The Yin-Yang of TCF/beta-catenin signaling. Adv Cancer Res. 2000;77:1–24. doi: 10.1016/s0065-230x(08)60783-6. [DOI] [PubMed] [Google Scholar]
  5. Behrens J., von Kries J. P., Kühl M., Bruhn L., Wedlich D., Grosschedl R., Birchmeier W. Functional interaction of beta-catenin with the transcription factor LEF-1. Nature. 1996 Aug 15;382(6592):638–642. doi: 10.1038/382638a0. [DOI] [PubMed] [Google Scholar]
  6. Brannon M., Brown J. D., Bates R., Kimelman D., Moon R. T. XCtBP is a XTcf-3 co-repressor with roles throughout Xenopus development. Development. 1999 Jun;126(14):3159–3170. doi: 10.1242/dev.126.14.3159. [DOI] [PubMed] [Google Scholar]
  7. Chan E. F., Gat U., McNiff J. M., Fuchs E. A common human skin tumour is caused by activating mutations in beta-catenin. Nat Genet. 1999 Apr;21(4):410–413. doi: 10.1038/7747. [DOI] [PubMed] [Google Scholar]
  8. He T. C., Chan T. A., Vogelstein B., Kinzler K. W. PPARdelta is an APC-regulated target of nonsteroidal anti-inflammatory drugs. Cell. 1999 Oct 29;99(3):335–345. doi: 10.1016/s0092-8674(00)81664-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Korinek V., Barker N., Morin P. J., van Wichen D., de Weger R., Kinzler K. W., Vogelstein B., Clevers H. Constitutive transcriptional activation by a beta-catenin-Tcf complex in APC-/- colon carcinoma. Science. 1997 Mar 21;275(5307):1784–1787. doi: 10.1126/science.275.5307.1784. [DOI] [PubMed] [Google Scholar]
  10. Li C., Bapat B., Alman B. A. Adenomatous polyposis coli gene mutation alters proliferation through its beta-catenin-regulatory function in aggressive fibromatosis (desmoid tumor). Am J Pathol. 1998 Sep;153(3):709–714. doi: 10.1016/s0002-9440(10)65614-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Miller J. R., Hocking A. M., Brown J. D., Moon R. T. Mechanism and function of signal transduction by the Wnt/beta-catenin and Wnt/Ca2+ pathways. Oncogene. 1999 Dec 20;18(55):7860–7872. doi: 10.1038/sj.onc.1203245. [DOI] [PubMed] [Google Scholar]
  12. Morin P. J., Sparks A. B., Korinek V., Barker N., Clevers H., Vogelstein B., Kinzler K. W. Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC. Science. 1997 Mar 21;275(5307):1787–1790. doi: 10.1126/science.275.5307.1787. [DOI] [PubMed] [Google Scholar]
  13. Munemitsu S., Albert I., Rubinfeld B., Polakis P. Deletion of an amino-terminal sequence beta-catenin in vivo and promotes hyperphosporylation of the adenomatous polyposis coli tumor suppressor protein. Mol Cell Biol. 1996 Aug;16(8):4088–4094. doi: 10.1128/mcb.16.8.4088. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Poon R., Smits R., Li C., Jagmohan-Changur S., Kong M., Cheon S., Yu C., Fodde R., Alman B. A. Cyclooxygenase-two (COX-2) modulates proliferation in aggressive fibromatosis (desmoid tumor). Oncogene. 2001 Jan 25;20(4):451–460. doi: 10.1038/sj.onc.1204107. [DOI] [PubMed] [Google Scholar]
  15. Roose J., Clevers H. TCF transcription factors: molecular switches in carcinogenesis. Biochim Biophys Acta. 1999 Oct 29;1424(2-3):M23–M37. doi: 10.1016/s0304-419x(99)00026-8. [DOI] [PubMed] [Google Scholar]
  16. Roose J., Huls G., van Beest M., Moerer P., van der Horn K., Goldschmeding R., Logtenberg T., Clevers H. Synergy between tumor suppressor APC and the beta-catenin-Tcf4 target Tcf1. Science. 1999 Sep 17;285(5435):1923–1926. doi: 10.1126/science.285.5435.1923. [DOI] [PubMed] [Google Scholar]
  17. Sagara N., Katoh M. Mitomycin C resistance induced by TCF-3 overexpression in gastric cancer cell line MKN28 is associated with DT-diaphorase down-regulation. Cancer Res. 2000 Nov 1;60(21):5959–5962. [PubMed] [Google Scholar]
  18. Tejpar S., Nollet F., Li C., Wunder J. S., Michils G., dal Cin P., Van Cutsem E., Bapat B., van Roy F., Cassiman J. J. Predominance of beta-catenin mutations and beta-catenin dysregulation in sporadic aggressive fibromatosis (desmoid tumor). Oncogene. 1999 Nov 11;18(47):6615–6620. doi: 10.1038/sj.onc.1203041. [DOI] [PubMed] [Google Scholar]
  19. Tetsu O., McCormick F. Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature. 1999 Apr 1;398(6726):422–426. doi: 10.1038/18884. [DOI] [PubMed] [Google Scholar]
  20. Zhou P., Byrne C., Jacobs J., Fuchs E. Lymphoid enhancer factor 1 directs hair follicle patterning and epithelial cell fate. Genes Dev. 1995 Mar 15;9(6):700–713. doi: 10.1101/gad.9.6.700. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES